Genetic Signatures Future Growth
Future criteria checks 2/6
Genetic Signatures is forecast to grow earnings and revenue by 74.6% and 51.1% per annum respectively. EPS is expected to grow by 80.1% per annum. Return on equity is forecast to be -2.6% in 3 years.
Key information
74.6%
Earnings growth rate
80.1%
EPS growth rate
Life Sciences earnings growth | 18.4% |
Revenue growth rate | 51.1% |
Future return on equity | -2.6% |
Analyst coverage | Low |
Last updated | 23 Feb 2024 |
Recent future growth updates
Recent updates
After Leaping 42% Genetic Signatures Limited (ASX:GSS) Shares Are Not Flying Under The Radar
Mar 08A Look At The Fair Value Of Genetic Signatures Limited (ASX:GSS)
Nov 14Genetic Signatures Limited (ASX:GSS) Investors Are Less Pessimistic Than Expected
Oct 10One Genetic Signatures Limited (ASX:GSS) Analyst Just Made A Major Cut To Next Year's Estimates
Jun 29Genetic Signatures (ASX:GSS) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of
Feb 28AU$3.20: That's What Analysts Think Genetic Signatures Limited (ASX:GSS) Is Worth After Its Latest Results
Feb 25What Kind Of Shareholders Hold The Majority In Genetic Signatures Limited's (ASX:GSS) Shares?
Feb 07What Does Genetic Signatures' (ASX:GSS) CEO Pay Reveal?
Jan 17Genetic Signatures' (ASX:GSS) Wonderful 522% Share Price Increase Shows How Capitalism Can Build Wealth
Dec 27Genetic Signatures (ASX:GSS) Is In A Strong Position To Grow Its Business
Dec 06Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
6/30/2026 | 43 | 1 | -8 | -1 | 1 |
6/30/2025 | 26 | -7 | -13 | -7 | 1 |
6/30/2024 | 10 | -17 | -12 | -6 | 1 |
12/31/2023 | 16 | -18 | -16 | -10 | N/A |
9/30/2023 | 19 | -16 | -18 | -11 | N/A |
6/30/2023 | 21 | -14 | -21 | -12 | N/A |
3/31/2023 | 22 | -11 | -16 | -8 | N/A |
12/31/2022 | 24 | -8 | -11 | -3 | N/A |
9/30/2022 | 30 | -3 | -2 | 3 | N/A |
6/30/2022 | 35 | 3 | 7 | 10 | N/A |
3/31/2022 | 33 | 3 | 4 | 7 | N/A |
12/31/2021 | 31 | 2 | 1 | 4 | N/A |
9/30/2021 | 30 | 2 | 0 | 4 | N/A |
6/30/2021 | 28 | 2 | -1 | 4 | N/A |
3/31/2021 | 29 | 3 | -3 | 2 | N/A |
12/31/2020 | 29 | 5 | -5 | -1 | N/A |
9/30/2020 | 21 | 1 | -9 | -5 | N/A |
6/30/2020 | 14 | -2 | -12 | -9 | N/A |
3/31/2020 | 11 | -3 | -8 | -6 | N/A |
12/31/2019 | 7 | -4 | -4 | -3 | N/A |
9/30/2019 | 7 | -4 | -3 | -3 | N/A |
6/30/2019 | 7 | -3 | -3 | -2 | N/A |
3/31/2019 | 7 | -3 | -3 | -2 | N/A |
12/31/2018 | 6 | -3 | -3 | -2 | N/A |
9/30/2018 | 5 | -3 | -4 | -3 | N/A |
6/30/2018 | 5 | -3 | -4 | -4 | N/A |
3/31/2018 | 5 | -3 | -4 | -3 | N/A |
12/31/2017 | 5 | -3 | -4 | -3 | N/A |
9/30/2017 | 4 | -3 | N/A | -3 | N/A |
6/30/2017 | 4 | -3 | N/A | -3 | N/A |
3/31/2017 | 4 | -3 | N/A | -2 | N/A |
12/31/2016 | 4 | -3 | N/A | -2 | N/A |
9/30/2016 | 3 | -3 | N/A | -2 | N/A |
6/30/2016 | 3 | -3 | N/A | -3 | N/A |
3/31/2016 | 3 | -3 | N/A | -3 | N/A |
12/31/2015 | 3 | -3 | N/A | -3 | N/A |
9/30/2015 | 2 | -3 | N/A | -3 | N/A |
6/30/2015 | 2 | -3 | N/A | -3 | N/A |
6/30/2014 | 1 | -2 | N/A | -1 | N/A |
6/30/2013 | 0 | -2 | N/A | -1 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: GSS is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: GSS is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: GSS is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: GSS's revenue (51.1% per year) is forecast to grow faster than the Australian market (5% per year).
High Growth Revenue: GSS's revenue (51.1% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: GSS is forecast to be unprofitable in 3 years.